BCL2 and cancer: To gain insights into possible cancer pathways that may be hijacked during SARS-CoV-2 infection, we evaluated the expression of molecular markers for cell proliferation (i.e., Ki-67), apoptosis (i.e., BCL-2), migration (i.e., VIM & MMP9), and angiogenesis (i.e., VEGF) in LV-infected 22VR1 and DLD-1 cells using RT-qPCR assay.